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Abstract
Background: Cardiomyopathy syndrome (CMS) is a severe disease affecting large farmed Atlantic salmon. Mortality
often appears without prior clinical signs, typically shortly prior to slaughter. We recently reported the finding and
the complete genomic sequence of a novel piscine reovirus (PRV), which is associated with another cardiac disease
in Atlantic salmon; heart and skeletal muscle inflammation (HSMI). In the present work we have studied whether
PRV or other infectious agents may be involved in the etiology of CMS.
Results: Using high throughput sequencing on heart samples from natural outbreaks of CMS and from fish
experimentally challenged with material from fish diagnosed with CMS a high number of sequence reads identical
to the PRV genome were identified. In addition, a sequence contig from a novel totivirus could also be
constructed. Using RT-qPCR, levels of PRV in tissue samples were quantified and the totivirus was detected in all
samples tested from CMS fish but not in controls. In situ hybridization supported this pattern indicating a possible
association between CMS and the novel piscine totivirus.
Conclusions: Although causality for CMS in Atlantic salmon could not be proven for either of the two viruses, our
results are compatible with a hypothesis where, in the experimental challenge studied, PRV behaves as an
opportunist whereas the totivirus might be more directly linked with the development of CMS.
Introduction
Cardiomyopathy syndrome (CMS) is a severe disease
primarily affecting large farmed Atlantic salmon (Salmo
salar L.). It was first reported in farmed salmon in
Norway in the mid-1980s [1,2], but has also been docu-
mented in farmed salmon in the Faroe Islands [3,4],
Scotland [5] and Canada [6]. In 2003, CMS-like lesions
were also reported in wild Atlantic salmon in Norway
[7]. Classically, the disease appears without prior clinical
signs in 2 to 5 kg sized fish from 12 to 15 months after
transfer to sea water until slaughter and may cause sub-
stantial economic losses [5,8]. The histopathological
changes of CMS are characterized by moderate to severe
inflammation of the heart, dominated by mononuclear
cell infiltration, mostly limited to the endocardium and
spongy myocardium in the atrium and ventricle [9,10].
Pathological changes in the compact myocardium and
epicarditis are rare and not considered typical findings.
Heart and skeletal muscle inflammation (HSMI) is
another disease of farmed Atlantic salmon in which car-
diac lesions are prominent, and is considered a differen-
tial diagnosis to CMS. HSMI has emerged as a disease
entity in Norwegian salmon farming with increasing
importance in the last decade. The disease outbreaks
are, in contrast to CMS, usually reported in smaller fish
(0.3 to 1 kg) 5 to 9 months after transfer to sea water
[11]. The morbidity, as estimated by histopathology,
may be high in affected cages, but the accumulated
mortality generally stays below 20%. The histopathologi-
cal changes of HSMI are characterized by moderate to
severe myocarditis with inflammation-associated necro-
sis of both spongy and compact myocardium in the
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severe epi- and endocarditis [12,13]. In contrast to fish
with CMS, fish with HSMI seem to be able to recover
with time.
We recently reported the finding and the complete
genomic sequence of a novel reovirus; piscine reovirus
(PRV), which is associated with HSMI in Atlantic sal-
mon [14]. In the present work we have studied the
potential role of PRV and other infectious agents in the
development of CMS using high throughput sequencing,
PCR and in situ hybridization. Our results indicated that
a hitherto unknown totivirus might be relevant for the
development of CMS whereas PRV may not be causally
associated with the disease.
Materials and methods
Pyrosequencing and PRV quantification in field samples
Total RNA was extracted using the RNeasy Lipid Kit
(QIAGEN AB, Oslo, Norway), from three specimens:
two heart samples from fish from a CMS outbreak
(peak phase with high mortality in the population) and
one combined heart and head kidney sample from an
experimentally challenged fish (nine weeks post inocula-
tion; see details below and [10]). The RNA was DNase
treated using TURBO DNA-free (Applied Biosystems/
Ambion, Austin, TX, USA) and reverse transcribed/
amplified using the QuantiTect kit (QIAGEN AB)
according to manufacturer’s instructions. Approximately
1 μg of RNA was used as template in each multiple dis-
placement amplification (MDA), which was allowed to
proceed for two hours. cDNA from the three reactions
was combined in equal amounts and a library with a
Multiplex Identifier tag was prepared according to the
GS FLX Titanium General Library Preparation Method
Manual (454 Life Sciences, a Roche company, Branford,
CT, USA). The library was titrated and amplified using
the large volume emulsion preparation protocol and
sequenced using a Genome Sequencer FLX instrument
and GS FLX Titanium chemistry (454 Life Sciences).
S e q u e n c i n gw a sd o n eb yt h eT h eN o r w e g i a nH i g h -
Throughput Sequencing Centre (NSC) at the University
of Oslo.
Virus PCR
Reverse transcription quantitative PCR (RT-qPCR) for
quantification of viral PRV RNA in CMS field samples
was performed as described earlier [14] using the minor
groove binding (MGB) assay targeting the L1 genomic
fragment. PRV RNA in head kidney and heart from 21
fish from four outbreaks of CMS was quantified and
compared to assumed healthy farmed fish.
Samples from challenged fish and controls were
obtained from ‘Challenge group 1’ described in a
previous publication [10]. Briefly, 100 unvaccinated wild
strain Atlantic salmon were intraperitoneally (i.p.)
injected with 200 μl supernatant of tissue homogenate
mix from six CMS diagnosed fish. Samples of heart,
head kidney, spleen and liver were taken from 5 fish
every third week 0 to 36 wpc (weeks post challenge),
and directly frozen at -80°C. Total RNA was isolated
using the RNeasy Mini Kit (QIAGEN AB). Each PRV
RT-qPCR run contained 100 ng RNA in a volume of
12.5 μl and the PCR protocol for detection of PRV
described in Palacios et al. [14] was used. Head kidney
s a m p l e sw e r ea l s os c r e e n e df o rt h ep r e s e n c eo fI P N V
(Infectious Pancreatic Necrosis Virus), SPDV (Salmon
Pancreas Disease Virus) and nodavirus by RT-qPCR.
The fish cultivation and research facilities were located
in an area geographically separated from the endemic
area of CMS in Norway.
A real-time PCR assay was designed for the totivirus
found in the 454 sequence database. A protocol identi-
cal to the one described above was used with forward
primer TTCCAAACAATTCGAGAAGCG, reverse pri-
mer ACCTGCCATTTTCCCCTCTT and the MGB
probe CCGGGTAAAGTATTTGCGTC (all written in
5’-3’ direction; Applied Biosystems, Life Technologies
Corporation, Carlsbad, California, USA). The assay was
used qualitatively to test both a panel of CMS outbreaks,
control samples and fish from the experimental
transmission.
In situ hybridization
In situ hybridizations were performed on heart sections
as described earlier [14] using LNA probes (Exiqon,
Vedbaek, Denmark) targeting PRV genomic segment L2
[14] and the totivirus RNA-dependent RNA polymerase
gene (probe sequences CTTCCGCTACCATCCTGA-
GATA and TTTCTTCGACACACCTTTCCGC; 5’-3’
direction). Viral RNA was visualized using aminoethyl-
carbazole (AEC). Heart sections of healthy fish served as
controls.
Comparison of PRV from CMS- and HSMI-affected fish
Genetic variation between PRV sequences from CMS
and HSMI outbreaks was estimated by comparing the
obtained CMS PRV reads with the corresponding con-
sensus genome segments from HSMI PRV (GenBank
accession numbers GU994013-GU994022). Using the
CLC Main Workbench (CLC bio, Aarhus, Denmark)
and default settings, each of the known HSMI PRV gen-
ome segments were consecutively used as a reference
for in silico assemblies of the CMS PRV reads. Each
CMS PRV assembly was inspected manually to identify
and evaluate conflicts between individual CMS PRV
reads and the HSMI PRV reference genome segments.
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High throughput sequencing
The pyrosequencing gave a total of 556,947 reads with
average length of 240 bases. Data are archived at
the National Center for Biotechnology Information
(NCBI) Sequence Read Archive (SRA) under accession
SRP002117. In order to perform computational subtrac-
tion of the reads, removal of ribosomal RNA reads or
assembly of read contigs would normally be performed,
but due to the possibility of having a significant number
of chimerical reads (the QuantiTect kit includes a liga-
tion step were the reversely transcribed cDNA frag-
ments are ligated to facilitate MDA) such filtering of
results was not done. Instead, all reads were analyzed
using Mega BLAST and a database comprising all
nucleotide sequences annotated as viral in the nr data-
base at NCBI was compiled. Mega BLAST searches
were conducted using word size 28 and for each read
the match that gave the highest bit score was recorded.
Results were tabulated and showed a large number of
hits to a relatively small number of entries in our viral
sequence database. Many of the sequences that showed
a high degree of similarity to our reads were obvious
errors in the nr database (incorrectly annotated/
assembled sequences, vector sequences etc.) and could
be discarded. Only four groups of sequences gave cred-
ible matches; eight reads were (imperfect matches) to
Chum salmon reovirus (accession number AF418297;
[15]), two matched Atlantic salmon swim bladder sar-
coma virus (acc. no. DQ174103; [16]) and 1,084 reads
matched the PRV genome with a very high degree of
sequence similarity. A 2,914 basepair sequence contig
comprising approximately 2,600 reads from what
appeared to be a novel virus could also be constructed.
Alignment of conserved amino acid sequence motifs in
the RNA-dependent RNA polymerase (RdRP) of the
Totiviridae indicated that the virus was related to this
virus family [17]. Using protein BLAST with default
parameters and 290 amino acids of RdRP, the closest
match was a gag-pol protein (27% identity; 45% positive)
from a totivirus infecting Giardia lamblia [18]. Partial
RdRP was control-sequenced using Sanger chemistry
and used as target for an MGB RT-qPCR assay and for
in situ hybridization (GenBank accession number
HQ401057).
PRV reads were assembled using the software
Sequencher (version 4.5; Gene Codes Corporation Ann
Arbor, MI, USA) and revealed approximately 85% cover-
age of the PRV genome. This was further increased to
94% coverage using Sanger sequencing of PCR amplified
fragments (data not shown). The genomic segments
showed considerable variation in coverage, both regard-
ing the relative part of the segments covered by reads
and the depth of coverage (Table 1). In particular, seg-
ments S1 and S2 showed relatively poor coverage. Most
of the longer fragments had reads that indicated the
presence of missense mutations.
PRV PCR
Screening of samples from field outbreaks of CMS
revealed only a modest increase in viral loads compared
to the elevated PRV titers seen in HSMI fish (Additional
File 1, Table S1 and [14]). In order to investigate further
the potential role of PRV in the experimental challenge
we quantified the viral loads in various organs through-
out the experiment. A general increase with time in
PRV RNA levels in all organ samples was found by RT-
qPCR 0 to 12 wpc (Figure 1). Six wpc, all organ samples
of all analyzed fish were positive. The levels of PRV
RNA peaked in head kidney 12 wpc (Ct 18.2) followed
by spleen 18 wpc (Ct 16.3). In heart and liver, the PRV
levels were in general lower than in the spleen and head
kidney, and remained stable from 15 wpc and onwards
with the highest levels detected 33 wpc (Ct 25.2) and 15
wpc (Ct 27.7), respectively. Heart control samples taken
3 ,6a n d9w p c( n =2 / t i m ep o i n t )w e r eP R Vn e g a t i v e
and the fish population was negative for SPDV and
nodavirus. Low and steady levels of IPNV (37 positives
of 67 samples, mean Ct ~30) were detected in the head
kidney from 6 wpc and onwards.
Totivirus PCR
Testing of samples from field outbreaks of CMS showed
a perfect correlation between the presence of totivirus
RNA and CMS (Table 2). All the control groups,
including HSMI outbreaks, were negative. Based on the
observation that there appeared to be a consistent rela-
tionship between the presence of virus and disease,
results were scored qualitatively (Table 2). Control fish
from the experimental challenge were negative and by
week six post challenge, all fish tested were positive for
the virus (Table 2).
Histopathology and localization of virus
The histopathological changes in the transmission
experiment have previously been described in detail
[10]. Briefly, the severity of atrial lesions peaked at 12
wpc, and remained at this level throughout the study.
Ventricular spongy layer lesions were found in ~50% of
the challenged fish from 12 wpc and onwards, and epi-
cardial changes were mild and decreased towards the
end of the study. Staining for PRV RNA by in situ
hybridization was seen in the spongious as well as the
compact myocardium, and in endocardial cells of areas
with distinct lesions and cellular infiltration. Staining for
totivirus RNA was seen in myocardial cells associated
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(Figure 2). Control sections were negative.
Discussion
The newly described piscine reovirus (PRV) belongs to
the Orthoreovirus/Aquareovirus group [19] within the
Reoviridae family [14]. Viruses of the two genera can
infect large groups of animals and cause diseases with a
broad range of manifestations; from inapparent to lethal.
The reoviruses are often considered ‘orphan’ as they
have not been definitely linked to particular diseases.
PRV is widely distributed in farmed Atlantic salmon in
sea water, and can be found in healthy as well as in dis-
eased fish [14]. It is thus not surprising that the virus
was present in the inoculumu s e di no u rC M Se x p e r i -
mental challenge. Totiviruses, on the other hand, are
Table 1 Estimation of genetic variation between HSMI PRV genome segments and CMS PRV sequence reads
Segment Length (nt) Transversions Transitions Amino acid changes Coverage
1 Depth
2
100%
3 >50%
4 ≥2
5 100% >50% ≥2 100% >50% ≥2- -
L1 3916 0 3 8 6 31 72 2 1 9 88.6% 13.55
L2 3935 0 5 5 1 60
6 44
7 0 4 11 96.3% 20.02
L3 3911 0 0 3 0 3 17 0 0 0 85.3% 17.43
M1 2383 0 1 0 13 0 3 0 0 0 63.7% 6.45
M2 2179 0 0 2 0 0 3 0 0 4 77.6% 28.92
M3 2403 0 0 0 1 0 6 0 0 2 84.7% 8.03
S1 1040 0 0 0 3 0 0 0 0 0 34.2% 3.15
S2 1329 0 0 0 0 3 0 0 0 0 33.1% 3.02
S3 1143 0 0 0 2 5 1 0 0 0 46.5% 3.00
S4 1081 0 0 0 0 0 0 0 0 0 54.0% 7.97
1 - Relative part of HSMI PRV segment covered by at least two reads in the CMS PRV sequence dataset.
2 - Average number of times each nucleotide position was sequenced (full length fragment).
3 - All CMS PRV reads exhibited the indicated feature.
4 - The majority of the CMS PRV reads exhibited the indicated feature.
5 - At least two CMS PRV reads exhibited the indicated feature.
6 - The majority of these transitions were found in the 5’-half of L2.
7 - The majority of these transitions were found in the 3’-half of L2.
Figure 1 Quantification of PRV RNA ± standard deviation (Ct values) in heart, spleen, head kidney and liver after intraperitoneal
injection challenge using RT-qPCR (n = 5/time point). Quantification of EF1a in heart tissue is shown as control. Asterisks indicate negative
PCRs.
Løvoll et al. Virology Journal 2010, 7:309
http://www.virologyj.com/content/7/1/309
Page 4 of 7primarily known to infect unicellular organisms such as
Saccharomyces cerevisiae and protozoans like Leishma-
nia and Giardia spp. [20], but the host range has
recently been found to include penaeid shrimp, insects
and some totiviruses can also be grown in mammalian
cell cultures [21]. Totiviruses are naked dsRNA viruses
and to our knowledge the closest link to our observation
of a totivirus in fish is the penaeid shrimp infectious
myonecrosis virus (PsIMNV) which causes necrosis in
the skeletal muscle of shrimp [22].
In the present study, histopathological lesions in the
heart consistent with CMS were observed from week 6
to the end (36 weeks) of the experimental infection. The
PRV and totivirus infections appeared to be persistent,
not only in immunologically important organs such as
the head kidney and spleen that often harbor persistent
and covert viral infections, but also in the heart, the
organ where the major histopathological lesions of CMS
are found. Neither HSMI nor CMS have been found in
the fresh water phase of farmed Atlantic salmon, but
both diseases occur after transfer to sea water. HSMI is
normally observed 5 to 9 months after transfer while
clinical CMS first appears after 12 to 18 months. Inde-
pendent challenge trials, as well as epidemiological
Table 2 Piscine totivirus PCR results
Sample set Type of sample Tissue Pos/n
440 CMS outbreak Heart/kidney 4/4
479 CMS outbreak Kidney 5/5
66 CMS outbreak Heart/kidney 5/5
89 CMS outbreak Heart/kidney 4/4
130 CMS outbreak Heart/kidney 10/10
52 CMS outbreak Heart/kidney 4/4
TP CMS outbreak Heart 10/10
253 HSMI outbreak Heart/kidney 0/2
694 HSMI outbreak Heart/kidney 0/2
SK07 HSMI outbreak Heart/kidney 0/2
PD561 Healthy, farmed Atlantic salmon Heart/kidney 0/6
PD1911 Healthy, farmed Atlantic salmon Heart/kidney 0/6
PD Healthy, farmed Atlantic salmon Heart/kidney 0/10
IRL Healthy, farmed Atlantic salmon Heart 0/3
WH Healthy, wild Atlantic salmon* Heart 0/23
Wpc0 CMS experimental transmission, prior to challenge Heart 0/5
Wpc3 CMS experimental transmission, week 3 Heart 1/2
Wpc6 CMS experimental transmission, week 6 Heart 2/2
Wpc9 CMS experimental transmission, week 9 Heart 2/2
Wpc21 CMS experimental transmission, week 21 Heart 5/5
Wpc33 CMS experimental transmission, week 33 Heart 4/4
Wpc36 CMS experimental transmission, week 36 Heart 4/4
* - multiple locations along the Norwegian coast.
Figure 2 In situ detection of PRV RNA and totivirus RNA (red) in heart sections from CMS diagnosed fish. (A) PRV RNA, (B) totivirus RNA.
Sections were counterstained with Meyer’s hematoxylin (blue).
Løvoll et al. Virology Journal 2010, 7:309
http://www.virologyj.com/content/7/1/309
Page 5 of 7studies, have indicated that CMS has an infectious cause
[9,10]. In combination with the late onset of CMS rela-
tive to sea water transfer this indicates that a persistent
infection is involved in the etiology. If an acute infection
is the primary cause of the disease, it should typically
have been observed also at earlier stages after sea water
transfer. In the field, CMS is often observed as sudden
death of large fish, caused by rupture of the atrium or
sinus venosus and resultant cardiac tamponade [2].
However, lesions characteristic of CMS develop over
several months until the myocardial lesions are severe
and widespread and the fish can no longer compensate
for the compromised function. Both experimental infec-
tions and field observations strongly indicate that CMS
is a chronic disease, culminating in sudden death, with
moderately elevated mortality rates. In cultured shrimp,
the totivirus PsIMNV causes a persistent, slowly pro-
gressive disease appearing as extensive necrotic areas in
striated muscles, with presence of the virus in heart
muscle [23]; a disease progression which has some
resemblance to CMS of farmed salmon, characterized by
degeneration and necrosis of the inner, spongious myo-
cardium of the ventricle and the atrium [2].
Significantly lower levels of PRV were found in fish
from field outbreaks of CMS than fish with a HSMI
d i a g n o s i s .T h et o t i v i r u sg a v eam o r ec o m p e l l i n gr e s u l t
where a perfect correlation was found between presence
of the virus and disease. Additional non-infectious fac-
tors such as fast growth have been suggested to be
important for development of CMS, and the highest
mortality is usually seen among fish with the highest
condition factor. Other contributing factors may include
lack of exercise, nutritional factors, environmental fac-
tors, stress and co-infections with other known or
unknown pathogens able to induce persistent infection
with heart involvement. It has been proposed that CMS
may be linked to previous viral infections, and an epide-
miological link between IPNV outbreaks in early sea
water phase and later outbreaks of CMS has been sug-
gested [8,24], but experimental transmission of CMS has
been demonstrated in the absence of IPNV [9].
Our sequence data were derived from total RNA
extracted from salmon sampled during field outbreaks
of CMS and fish where CMS had been induced through
experimental transmission. Viral reads were identified
using nucleic/amino acid sequence similarity search
tools and thus the absence of other candidates becomes
significant. The possibility that another, causal virus,
was transferred along with PRV and the totivirus in the
experimental challenge cannot be excluded. Bioinfor-
matics tools may not have identified the virus, or viral
titers may have been too low for detection.
For PRV to be causally involved in two distinct
diseases such as CMS and HSMI, the most likely
explanation would be that there are different genotypes
of the virus. The fish farming industry has many simila-
rities with the poultry industry, such as the production
of a large number of a single animal species in an
industrial scale within a confined area. The avian reo-
viruses (ARV) of the Orthoreovirus genus are important
pathogens of poultry and cause considerable economic
loss in the industry. Like PRV, ARV is ubiquitous in
production units and the etiology of specific diseases
attributed to ARVs are difficult to reproduce experi-
mentally [25]. The pathogenicity of ARV strains differs
considerably and the infections may not cause recogniz-
able diseases or clinical signs at all. The gene encoding
the neutralizing antibody inducing viral attachment pro-
tein sC, shows nucleotide variation in circulating field
strains that has affected the efficacy of vaccines [26].
The analogous protein in mammalian orthoreovirus, s1,
appears to affect tissue tropism and pathogenesis in
mice [27]. A hypothesis could be that the sequence
diversity between PRV strains (Table 1) may account
for the distinct appearances of HSMI and CMS. How-
ever, sequencing of the assumed sC/s1a n a l o g u eo f
PRV from a number of CMS/HSMI outbreaks did not
show any distinct pattern (data not shown).
The viral load and localization of totivirus in myocar-
dial cells of heart lesions characteristic of CMS indicate
that the totivirus is involved in the disease development.
The load of PRV in fish with experimentally induced
CMS and the persistence of the infection in the heart
indicate that PRV may be opportunistically associated
with the development of CMS, but we believe that the
totivirus is a more likely causative candidate.
Additional material
Additional file 1: PRV titres in CMS field outbreaks. Relative loads of
PRV in four different CMS field outbreaks.
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